VanEck Vectors Valuation

VanEck Vectors Biotech ETF -- USA Etf  

USD 131.57  2.25  1.74%

VanEck Vectors Biotech has current Real Value of $127.45 per share. The regular price of the etf is $131.57. At this time the etf appears to be over valued. Macroaxis measures value of VanEck Vectors Biotech from inspecting the etf fundamentals such as Number of Employees of 6, Five Year Return of 18.69% and Price to Earning of 17.66times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securites prices and their ongoing real values will draw towards each other.
 Time Horizon     30 Days    Login   to change
VanEck Vectors Biotech ETF is the top ETF in price to earning as compared to similar ETFs. It is third largest ETF in three year return as compared to similar ETFs reporting about  0.17  of Three Year Return per Price to Earning. The ratio of Price to Earning to Three Year Return for VanEck Vectors Biotech ETF is roughly  5.93 
Over Valued
January 22, 2018
131.57
Market Value
Downside upside
Downside
124.54
127.45
Real Value
Target Price Odds
 Above  Below  
144.73
Upside
Upside upside
VanEck Vectors is not too risky asset. Calculation of real value of VanEck Vectors Biotech is based on 1 month time horizon. Increasing VanEck Vectors Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Net Asset

VanEck Vectors Net Asset Analysis
VanEck Vectors Biotech ETF is the top ETF in net asset as compared to similar ETFs. Total Asset Under Management (AUM) of Health category is currently estimated at about 877.65 Million. VanEck Vectors totals roughly 591.53 Million in net asset claiming about 67% of all ETFs under Health category.